ISX (Isoxsuprine HCL)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ISX (Isoxsuprine HCL), covering 2024-02-06 to 2024-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses [Phase 1, Phase 2]